BANK VONTOBEL/CALL/BIOGEN IDEC/330/0.01/21.06.24 | Delayed Deutsche Boerse AG 04:24:00 2024-06-14 am EDT | ||
| 0.001 EUR | 0.00% |
|
| 6 months | -97.73% | ||
| Current year | -98.21% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-14 | 0.001 | 0.00% |
| 24-06-13 | 0.001 | 0.00% |
| 24-06-12 | 0.001 | 0.00% |
| 24-06-11 | 0.001 | 0.00% |
| 24-06-10 | 0.001 | 0.00% |
Delayed Quote Deutsche Boerse AG
Last update June 14, 2024 at 04:24 am EDT
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | 
Vontobel
|
| WKN | VU9CYX |
| ISIN | DE000VU9CYX7 |
| Date issued | 2023-07-03 |
| Strike | 330 $ |
| Maturity | 2024-06-21 (8 Days) |
| Parity | 100 : 1 |
| Emission price | 0.23 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.27 € |
|---|---|
| Lowest since issue | 0.001 € |
| Delta | 0.06x |
| Omega | 12.24 |
| Premium | 41.6x |
| Gearing | 208.44x |
| Moneyness | 0.7086 |
| Difference Strike | 96.16 $ |
| Difference Strike % | +29.14% |
| Spread | 0.019 € |
| Spread % | 95.00% |
| Intrinsic value | 0.000000 |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
233.8
USD
Average target price
284.6
USD
Spread / Average Target
+21.73%
- Stock Market
- Warrants
- Warrant
